BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22946916)

  • 1. Strategies to estimate and improve drug tolerance in anti-drug antibody assays.
    Bütikofer L; Lemaillet G; Faust H
    Bioanalysis; 2012 Aug; 4(16):1999-2012. PubMed ID: 22946916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.
    Mikulskis A; Yeung D; Subramanyam M; Amaravadi L
    J Immunol Methods; 2011 Feb; 365(1-2):38-49. PubMed ID: 21130095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodies.
    Stubenrauch K; Mackeben K; Vogel R; Heinrich J
    Anal Biochem; 2012 Nov; 430(2):193-9. PubMed ID: 22935295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
    Qiu ZJ; Ying Y; Fox M; Peng K; Lewin-Koh SC; Coleman D; Good J; Lowe J; Rahman A; Yang J; Jiang J; Quarmby V; Song A
    J Immunol Methods; 2010 Oct; 362(1-2):101-11. PubMed ID: 20868690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.
    Li J; Schantz A; Schwegler M; Shankar G
    J Pharm Biomed Anal; 2011 Jan; 54(2):286-94. PubMed ID: 20869832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug.
    Bourdage JS; Cook CA; Farrington DL; Chain JS; Konrad RJ
    J Immunol Methods; 2007 Oct; 327(1-2):10-7. PubMed ID: 17716682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays.
    Zoghbi J; Xu Y; Grabert R; Theobald V; Richards S
    J Immunol Methods; 2015 Nov; 426():62-9. PubMed ID: 26255760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore.
    Sickert D; Kroeger K; Zickler C; Chokote E; Winkler B; Grenet JM; Legay F; Zaar A
    J Immunol Methods; 2008 May; 334(1-2):29-36. PubMed ID: 18304570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology.
    Huhtinen P; Soukka T; Lövgren T; Härmä H
    J Immunol Methods; 2004 Nov; 294(1-2):111-22. PubMed ID: 15604021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers.
    Liu Y; Reidler H; Pan J; Milunic D; Qin D; Chen D; Vallejo YR; Yin R
    J Pharmacol Toxicol Methods; 2011; 64(3):238-45. PubMed ID: 21827863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic study of the effect of low pH acid treatment on anti-drug antibodies specific for a domain antibody therapeutic: Impact on drug tolerance, assay sensitivity and post-validation method assessment of ADA in clinical serum samples.
    Kavita U; Duo J; Crawford SM; Liu R; Valcin J; Gleason C; Dong H; Gadkari S; Dodge RW; Pillutla RC; DeSilva BS
    J Immunol Methods; 2017 Sep; 448():91-104. PubMed ID: 28625864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel drug and soluble target tolerant antidrug antibody assay for therapeutic antibodies bearing the P329G mutation.
    Wessels U; Schick E; Ritter M; Kowalewsky F; Heinrich J; Stubenrauch K
    Bioanalysis; 2017 Jun; 9(11):849-859. PubMed ID: 28517957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA.
    Smith HW; Butterfield A; Sun D
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):230-7. PubMed ID: 17869396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an antibody capture and a cell capture ligand-binding assay to quantify a monoclonal therapeutic in serum.
    Spriggs F; Aggarwal P; Deng S; Soderstrom C; Donovan C
    Bioanalysis; 2011 Mar; 3(6):605-11. PubMed ID: 21417730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of drug interference in immunogenicity assays.
    Hart MH; de Vrieze H; Wouters D; Wolbink GJ; Killestein J; de Groot ER; Aarden LA; Rispens T
    J Immunol Methods; 2011 Sep; 372(1-2):196-203. PubMed ID: 21824477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming soluble target interference in an anti-therapeutic antibody screening assay for an antibody-drug conjugate therapeutic.
    Carrasco-Triguero M; Mahood C; Milojic-Blair M; Amaya C; Ruppel J; Hong K; Yi JH; Kaur S
    Bioanalysis; 2012 Aug; 4(16):2013-26. PubMed ID: 22946917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera.
    Hoesel W; Gross J; Moller R; Kanne B; Wessner A; Müller G; Müller A; Gromnica-Ihle E; Fromme M; Bischoff S; Haselbeck A
    J Immunol Methods; 2004 Nov; 294(1-2):101-10. PubMed ID: 15604020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum.
    Wang SL; Ohrmund L; Hauenstein S; Salbato J; Reddy R; Monk P; Lockton S; Ling N; Singh S
    J Immunol Methods; 2012 Aug; 382(1-2):177-88. PubMed ID: 22691619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.
    Tornetta M; Fisher D; O'Neil K; Geng D; Schantz A; Brigham-Burke M; Lombardo D; Fink D; Knight D; Sweet R; Tsui P
    J Immunol Methods; 2007 Dec; 328(1-2):34-44. PubMed ID: 17888945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.